Psilocybin, the active compound in "magic mushrooms," has gained significant attention in recent years due to its potential therapeutic benefits. As conversations around mental health treatments evolve, New York is starting to see a growing interest in psilocybin therapy. While psilocybin remains classified as a controlled substance under state and federal law, there are ongoing legislative efforts to reform its legal status.

‍

This article provides a comprehensive overview of the legal landscape surrounding psilocybin in New York, including its current status, decriminalization efforts, and potential access to psilocybin therapy. We’ll also delve into its medical applications, exploring the latest research and developments in psilocybin’s use for mental health treatments like depression and post-traumatic stress disorder (PTSD). By the end, you'll have a clear understanding of the legal status and potential benefits of psilocybin in New York.

‍

‍

What is Psilocybin?

‍

Psilocybin is a naturally occurring psychedelic compound found in certain species of mushrooms. Once ingested, it is converted into psilocin, which interacts with serotonin receptors in the brain, particularly the 5-HT2A receptor. This interaction alters brain activity, especially within the default mode network (DMN), which is related to self-reflection and rumination. The disruption of the DMN during a psilocybin experience can lead to ego dissolution and enhanced brain connectivity, promoting emotional and cognitive flexibility.

‍

Studies suggest that psilocybin may foster neuroplasticity, allowing the brain to form new neural connections, which can help treat conditions like depression, anxiety, and addiction. The therapeutic effects of psilocybin, combined with psychotherapy, can last for months after just one or two doses. However, potential risks include nausea, anxiety, and psychological distress, making it crucial that psilocybin therapy is conducted in controlled settings with professional oversight.

‍

Read: The Safety of Psilocybin Therapy 

‍

‍

Current Legal Status of Psilocybin in New York

‍

Psilocybin New York: State Laws and Regulations

In New York, psilocybin remains a Schedule I controlled substance under both state and federal law as of October 2024. As a Schedule I drug, psilocybin is classified as having no accepted medical use and a high potential for abuse, making its possession, sale, and cultivation illegal. This classification aligns with federal law under the Controlled Substances Act, which imposes severe penalties for unauthorized use or distribution.

‍

Two notable bills have also been introduced to the New York State Senate, Assembly Bill A10375 in May 2024 and Assembly Bill A03581in February 2023. Both are in consideration in the assembly committee as of October 2024.

• Bill A3581A: This bill proposes the medical use of psilocybin in New York under controlled conditions. It outlines a framework for lawful psilocybin use in therapeutic settings, including certification for facilitators, protections for medical use, and the creation of a Psilocybin Assisted Therapy Advisory Board. The bill also includes a pilot program for naturally grown psilocybin and establishes a grant program for veterans and low-income individuals to access psilocybin-assisted therapy.
• Bill A10375: This bill establishes the Psilocybin Research Advisory Council in New York to guide research on psilocybin's medical use. The council is tasked with evaluating and advising the state on psilocybin research, including providing grants for clinical trials investigating the therapeutic effects of whole-mushroom psilocybin on conditions like PTSD, depression, and substance use disorders. It prioritizes veterans and first responders as research subjects and ensures participants are protected from prosecution during trials.

‍

While the legal framework remains strict, increasing public and political support for psychedelic reform could pave the way for future changes to the legal status of psilocybin in New York.

‍

Ongoing Research

Attitudes around psilocybin are evolving both nationally and within New York. NYU Langone Health’s Center for Psychedelic Medicine is currently performing clinical trials for many different applications of psychedelic-assisted services, including: 

• Psilocybin-assisted therapy for smoking cessation
• Psilocybin-assisted therapy for depression and anxiety in advanced cancer
• Psilocybin for the treatment of Major Depressive Disorder (MDD)
• Neurobehavioral mechanisms of psilocybin-assisted treatment for Alcohol Use Disorder

‍

How to Access Psilocybin Legally in New York

‍

Currently, there are no legal means for the public to access psilocybin services in New York, as it remains a Schedule I controlled substance under both state and federal law. This classification makes the possession, sale, and cultivation of psilocybin illegal, with severe penalties for violation.

‍

For now, those seeking legal, guided psilocybin therapy can consider retreats in states like Oregon and Colorado. Odyssey offers such experiences, providing professionally guided, evidence-based psilocybin sessions in compliance with these states’ legal frameworks.

‍

‍

Medical & Therapeutic Applications

‍

Mental Health Benefits

Psilocybin has emerged as a powerful tool in mental health treatment, showing promising results for conditions like major depression (MDD), end-of-life anxiety, post-traumatic stress disorder (PTSD), and substance use disorder. 

‍

Studies have demonstrated that a single dose of psilocybin, when paired with therapy, can lead to profound mood improvements that last for months. This effect is thought to be connected to psilocybin’s ability to reduce overactivity in the default mode network (DMN), a brain region linked to self-reflective and ruminative thinking, often heightened in those with depression.

‍

In addition to its impact on depression, psilocybin has shown potential in reducing anxiety, particularly among individuals facing terminal illnesses. Clinical trials indicate that patients treated with psilocybin report a significant improvement in emotional well-being, helping them address existential distress and fears related to the end of life. Similarly, psilocybin-assisted therapy is being explored as a treatment for PTSD, where it helps patients process trauma more effectively by diminishing fear-based responses and promoting emotional healing.

‍

Research has also shown early signals of effectiveness in treating addiction, particularly in reducing alcohol and nicotine dependence. Psilocybin, when combined with therapy, can offer a psychological "reset," helping individuals reassess their addictions and initiate long-term behavior change. Psilocybin's interaction with serotonin receptors (5-HT2A) is believed to play a critical role in these therapeutic outcomes, promoting mental flexibility, emotional resilience, and a greater sense of psychological well-being.

‍

Read: Psilocybin Therapy for Depression and Psilocybin Therapy for Obsessive-Compulsive Disorder (OCD)

‍

‍

Conclusion

The landscape surrounding psilocybin in New York is rapidly evolving. While it remains a Schedule I controlled substance, ongoing legislative efforts indicate shifting attitudes toward its potential therapeutic benefits. New York lawmakers are exploring pathways to legalize psilocybin-assisted therapy, which could provide a safe and regulated means for individuals to address mental health challenges such as depression, anxiety, and PTSD.

‍

Although there are currently no legal avenues for accessing magic mushrooms within New York state, significant research is being conducted at institutions like NYU Langone's Center for Psychedelic Medicine. As the state continues to evaluate its stance on psychedelics, New Yorkers may soon have access to psilocybin therapy in a clinical, regulated environment, following the models set by Oregon and Colorado.

‍

For those seeking immediate access to psilocybin therapy, Odyssey offers legal, evidence-based retreats in states where psilocybin is regulated, providing safe and professionally guided experiences for self exploration and mental health support.

‍

‍

Psilocybin in New York – FAQs

‍

Is psilocybin legal in New York?

• No, psilocybin is currently illegal in New York state. It remains a Schedule I controlled substance under state and federal laws, which prohibits its possession, sale, or cultivation. However, ongoing legislative efforts could lead to changes in its legal status for therapeutic use.

‍

Where can I legally access psilocybin?

• At present, psilocybin therapy is only legally available in Oregon and Colorado, where it has been legalized for supervised use in licensed centers. Residents of other states can access legal psilocybin experiences by traveling to these states.

‍

Can I grow magic mushrooms at home in New York?

• No, home cultivation of magic mushrooms is illegal in New York. Current laws prohibit the personal cultivation of any psilocybin-containing fungi. Proposed legislation may allow adults to cultivate for personal use if they acquire a permit, but this is not yet in effect.

‍

What are the benefits of psilocybin therapy?

• Psilocybin therapy has shown promise in treating depression, anxiety, PTSD, and addiction. Research suggests it can enhance neuroplasticity, allowing individuals to break negative thought patterns and achieve long-term improvements in mental health conditions.

‍